Nrgaard CH, Friedrich S, Hansen CT, et al
A cardiovascular prognosis evaluation trial of semaglutide in the treatment of T2DM reported that administration of semaglutide reduced the cardiovascular prognostic risk (110)
Back Holst, JJ, rskov,C, Schwartz, TW, et al (29 Aug 1986) 'Proglucagon 78-107, a potent insulinotropic hormone from lower smaller intestine', Diabetologia:Abstracts , 511A-610A.Back Holst, JJ, rskov, C, Vagn Nielsen, O, Schwartz, TW (1987) 'Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut', FEBS letters , 211/2
If you take GLP-1 medication and want plastic surgery, your medication timing, symptoms, weight stability, and anesthesia plan all matter